http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2367921-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2becc3642f2fd1e03f63bf24e23a1111
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N55-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H7-06
filingDate 2000-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6d2b380a290352cc52965f6335869a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3a7f2aab42582c730b203f26ee76d6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_963ef50d8f7b9199ca022f061d9be66d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab6a7714b379d1d7fe28b5c31240e312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b640650ad45fb9b86b0a9db7f09d820
publicationDate 2000-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2367921-A1
titleOfInvention Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents
abstract Compounds of the formula (I), their tautomers, their salts and their water addition products, (see formula I) where the radicals and symbols A, D, E, G and L are as defined in claim 1 and, for example, A = N, CR; D = C or N, E = a) an N atom or C-R O, if in each case D = N, or b) N-R O, -O-, -S-, -SO- or -SO2-, if in each case D = C, the line of dots (.cndot..cndot..cndot..cndot..cndot.) from D via a ring carbon atom to E is a double bond between the ring carbon atom and E if D = N (case a), or is a double bond between ring carbon atom and D if D = C (case b), R, R O = H or an aliphatic or aromatic radical (see claim 1); G is a divalent hydrocarbon bridge having 1-24 carbon atoms in the chain, in which chain members can be replaced by O, S, NH, (C1-C4)alkyl-N or acyl-N, and, in the unsaturated case, by an N atom, where the bridge is unsubstituted or substituted, L, L* independently of one another are each OR4, SR4, CN, tetrazolo, C(OR5)(OR6)(OR7), -Z1, -O-Z2, -S-Z2 or -NH-Z2, where L may be attached cyclically to G via a second direct bond or via a heteroatom N, O or S, Z1, Z2 are each the radical of an oxygen acid Z1-OH and Z2-OH, respectively, R1 to R7 = H or an organic radical (see claim 1), are direct or indirect inhibitors of the enzyme adenosine monophosphate deaminase (AMPDA) or adenosine deaminase (ADA) and are suitable for use as herbicides or pharmaceuticals for the treatment of diseases which can be treated by inhibiting the enzyme AMPDA or ADA. For the preparation, cf. claims 8-12.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10745427-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11472826-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9487544-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019055273-A1
priorityDate 1999-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 55.